Musaffa Logo
scPharmaceuticals Inc SCPH

Last Updated: Oct 06, 12:00 AM·BE

SCPH Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, scPharmaceuticals Inc is classified as halal.

HALAL

Report Source: 2025 2nd Quarter Report

scPharmaceuticals Inc

scPharmaceuticals Inc. Stock Analysis SCPH

Germany Health Care Small Cap Report:
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. The company is headquartered in Burlington, Massachusetts and currently employs 162 full-time employees. The company went IPO on 2017-11-17. The firm is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company’s strategy is to develop therapies for subcutaneous administration that have previously been limited to intravenous (IV) delivery. Its commercial product, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. The Company’s pipeline programs include SCP-111 (furosemide injection) 80mg/mL is an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home.
Read More

scPharmaceuticals Inc (SCPH) Chart

Key Statistics of scPharmaceuticals Inc (SCPH)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€5.65€5.71

Today's Open

€5.68

Volume

10.90M

P/E Ratio (TTM)

-

52 Week Range

€4.13€6.28

Market Cap

259.34M

Avg. Volume

1.92M

Dividend Yield

-

Financial Metrics & Statements of scPharmaceuticals Inc (SCPH)

Super Investors Invested in scPharmaceuticals Inc (SCPH)

FAQ's for scPharmaceuticals Inc (SCPH)

  • As of July 2026, scPharmaceuticals Inc SCPH is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes scPharmaceuticals Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in scPharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of scPharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of scPharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of scPharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.